KWS SAAT SE & Co. KGaA Overview
| Item | Detail |
|---|---|
| Legal name | KWS SAAT SE & Co. KGaA |
| Former names | KWS SAAT SE (before conversion to KGaA, 2019); KWS SAAT AG; KWS Kleinwanzlebener Saatzucht AG |
| Personally liable partner | KWS SE (its Executive Board manages the business) |
| Founded | 1856, Klein Wanzleben (near Magdeburg), Germany (AR 25/26: "Since it was founded in 1856…") |
| Incorporation jurisdiction | Germany (Societas Europaea & Co. KGaA under German law) |
| Headquarters | Grimsehlstraße 31, 37574 Einbeck, Lower Saxony, Germany (street address from company records; HQ city confirmed in AR 25/26) |
| Listing | Frankfurt Stock Exchange (XETRA, Prime Standard), SDAX index; also traded on SIX Swiss Exchange, regional German exchanges (Frankfurt, Düsseldorf, Hamburg, Munich), Vienna; US OTC (KNKZF) |
| Ticker | KWS (XETRA) |
| ISIN / WKN | DE0007074007 / 707400 |
| CUSIP | Not applicable (no US listing; n/d) |
| Shares outstanding | 33,000,000 no-par bearer shares (AR 25/26) |
| Fiscal year end | 30 June |
| Employees (avg. headcount, excl. seasonal) | 5,235 in FY2025/26; 5,102 in FY2024/25 (AR 25/26) |
| Employees (avg. FTE, continuing ops) | 4,983 (FY25/26), 4,837 (FY24/25), 4,673 (FY23/24) (AR 25/26) |
| Auditor | EY GmbH & Co. KG Wirtschaftsprüfungsgesellschaft, Stuttgart (FY2025/26); PricewaterhouseCoopers GmbH proposed as auditor from FY2026/27 (AR 25/26, Supervisory Board report) |
| Market capitalization | €2,244m at 30 Jun 2026 (AR 25/26, €67.40 close); approx. €2.3bn at c. €70 per share following the 23 Sep 2026 results sell-off (market data; analyst-derived) |
| Website | www.kws.com (corporate: www.kws.com/corp/en/) |
| Shareholder structure | Families Büchting, Arend Oetker and Tessner 69.3% (of which Tessner Beteiligungs GmbH 15.4%); free float 30.7% (AR 25/26, at 30 Jun 2026) |
The name supplied ("KWS SAAT SE") is a former legal name. The entity profiled is the listed parent of the KWS Group, KWS SAAT SE & Co. KGaA, a German partnership limited by shares (KGaA) whose sole personally liable partner is KWS SE. It is an active, publicly listed company (SDAX constituent), consistent with the "Public company" type supplied.
| Metric | FY2021/22 | FY2022/23 | FY2023/24 | FY2024/25 | FY2025/26 |
|---|---|---|---|---|---|
| Employees avg FTE (number) | 4,222 | 4,391 | 4,673 | 4,837 | 4,983 |
| Personnel expenses (EUR M) | 327.9 | 371.4 | 397.1 | 442.8 | 456.8 |
Source: AR 25/26, "KWS in Figures".
KWS is the world's largest independent, pure-play plant-breeding company and the global market leader in sugarbeet seed. Founded in 1856 and still controlled (69.3%) by three founding-related families, it breeds, multiplies and sells proprietary seed across sugarbeet, European silage and grain corn, sunflower, hybrid rye, wheat, barley, oilseed rape and — increasingly — vegetables. Unlike its large competitors (Bayer, Corteva, Syngenta, BASF), KWS has no crop-protection chemistry business, positioning itself as a "seed specialist" that partners with chemistry firms rather than competing with them. Following divestments of its Chinese, South American and North American corn businesses (2023–2025), KWS has reshaped itself into a Europe-centred, high-margin company with near-zero net debt (€8.7m at June 2026). With R&D intensity of c. 21% of sales (€342m in FY2025/26), it competes on genetic innovation, targeting 3–5% organic growth and 19–21% EBITDA margins over 2025–2028.
What the company does
KWS develops new plant varieties through conventional and hybrid breeding supported by genomics, phenotyping, data science and (prospectively) genome editing; multiplies seed through contract growers and its own farms; processes, pellets and treats seed; and markets it to farmers via distributors, cooperatives, sugar processors and direct sales. It also licenses genetics and traits (e.g., through its TraitWay licensing platform) and provides agronomic advisory and digital tools (myKWS, KWS INITIO).
The company's own description (AR 25/26, section 2.1.1, paraphrased): since 1856 KWS has specialised in breeding, producing and distributing high-quality agricultural seed; it covers the complete value chain of a modern seed producer — from variety development through propagation, processing and marketing to farmer consulting. Its core competence lies in breeding regionally adapted, high-performing varieties that require fewer inputs; breeding resistances against fungi or viruses allows lower pesticide use; and the business model rests on the added value each new variety delivers through breeding progress, seed quality and targeted advice.
Business model and revenue model
| Revenue type | Description | Estimated weight |
|---|---|---|
| Product (seed sales) | Proprietary seed of own varieties sold per unit (sugarbeet: per unit of 100,000 pelleted seeds; corn: per bag/unit; cereals: certified seed) | Vast majority of €1,626.8m FY25/26 sales; exact split n/d |
| Licensing / royalties | Variety royalties on farm-saved and multiplied seed (cereals), trait licensing (TraitWay), sale of license rights (e.g., €29.0m one-off licence-right sale tied to the North American corn divestment, FY25/26) | n/d (one-offs disclosed) |
| Services | R&D services (e.g., c. €14m in FY24/25 for divested North American corn activities — portfolio effect, AR 25/26), agronomic consulting | Small; n/d |
| Farming | Revenue from own farms in Germany, France, Poland (Corporate segment) | €7.5m FY25/26 (AR 25/26) |
| Subscription | None material | — |
The model is IP-driven: margins depend on breeding progress (yield, disease tolerance, herbicide-tolerance systems) protected by plant variety protection, hybrid biology (hybrids cannot be meaningfully farm-saved, creating annual repurchase) and patents (e.g., traits in CONVISO SMART sugarbeet). Gross margin was 61.2% in FY25/26 (63.1% FY24/25) (AR 25/26).
Value-chain position
KWS sits at the very start of the food chain: genetics → seed production → (distributor/co-op/sugar factory) → farmer → processor (sugar factory, feed mill, biogas plant, oil mill, food processor) → consumer. In sugarbeet, sugar processors often coordinate seed purchasing for contracted growers, giving KWS concentrated, relationship-based channels. KWS does not manufacture crop-protection chemicals; herbicide-tolerance systems (e.g., CONVISO SMART) are co-developed with a chemistry partner (Bayer supplies the CONVISO ONE herbicide — from public product information; contractual details n/d).
Customer types and end-markets
| Customer group | End-market | Key crops |
|---|---|---|
| Arable farmers (large and family farms) | Food, feed, energy | Sugarbeet, corn, cereals, oilseed rape, sunflower |
| Sugar processors / cooperatives | Sugar, bioethanol | Sugarbeet |
| Livestock and biogas farms | Feed (silage), biogas | Silage corn |
| Seed distributors, agri-retail, co-ops | All | All field crops |
| Professional vegetable growers (open field, protected/greenhouse), food-service supply chains | Fresh and processed vegetables | Spinach, beans, Swiss chard, red beet, tomato, pepper, cucumber, melon, watermelon |
| Other breeders / licensees | Genetics licensing | Traits, germplasm |
Independent characterisation
KWS is best understood as a sugarbeet franchise funding a portfolio of growth options. Sugarbeet generated 52.5% of FY25/26 sales but, at €358.1m segment EBITDA, more than 100% of group EBITDA before Corporate costs (AR 25/26). Corn (now Europe-only), cereals (with oilseed rape as the fastest grower) and vegetables (still loss-making) represent diversification and option value. Following the 2023–2025 exits from China, South America and North America corn, the group's risk profile has shifted from leveraged geographic expansion to a cash-generative, Europe-centric specialist with a fortress balance sheet (equity ratio 61.2%) — but also with higher concentration in EU agricultural policy, sugar prices and acreage cycles.
Strategy
Stated strategy (AR 25/26; CMD 18 Nov 2025)
The strategic planning (10-year horizon), updated in FY2024/25 and referred to as "Strategic Planning 2035" by the Supervisory Board, rests on three pillars (paraphrased): (1) expand and defend leadership in established field crops (sugarbeet, European corn, cereals/OSR) with a full crop-rotation portfolio; (2) build activities with additional value potential, chiefly vegetable seed; (3) drive breeding innovation, exploiting hybrid breeding and new breeding technologies such as genome editing, plus digital tools and services. The CMD tagline was "Specialized in seeds. Powered by innovation. Delivering profitable growth." KWS's stated vision is "Seeding the future for generations."
Medium-term targets (2025–2028)
| Target | Value | Status FY25/26 |
|---|---|---|
| Organic net sales growth | Average 3–5% p.a. | −1.0% (miss) |
| EBITDA margin | 19–21% | 19.3% adjusted (in range, low end) |
| Dividend payout | 25–30% of adjusted net income; high continuity | 28.9% |
| R&D | Continuous, significant spending | €342.1m, 21.0% of sales |
| Sustainability | Ambition 2035 targets | Published Jul 2026 |
Strategic initiatives (last 24 months)
| Initiative | Description | Timing / target |
|---|---|---|
| Corn portfolio refocus | Exit China, South America, North America; focus on profitable European corn | Completed Sep 2025 |
| Vegetables build-out | Commercialise all nine vegetable crops; R&D centers Andijk, Uberlândia | All crops on market FY26/27; c. €100m sales by 2030 |
| Sunflower growth | New high-performance varieties | €100m sales by 2035 |
| Hybrid wheat | BLA (blue aleurone) hybridisation system | First products first half of 2030s |
| Hybrid barley | UK launch, further approvals pending | Ongoing |
| TRUVERA sugarbeet (US) | Triple-stack herbicide tolerance | Launch planned FY26/27 |
| Genome editing readiness | Pipeline in disease/pest resistance (e.g., OSR flea beetle) | EU NGT rules expected to apply c. 2 years after June 2026 approval |
| "Your Seed Partner" | Holistic, cross-crop farmer advisory | Ongoing |
| Cost programme | Cost-cutting initiated H1 FY25/26 | Function costs reduced; no quantified savings target disclosed (n/d) |
| Digitalisation | New ERP implementation; AI use cases in admin, sales, R&D | Ongoing |
| Infrastructure | Einbeck phytopathology center (c. €25m), Gran Canaria greenhouse, Kimberly greenhouses | 2025–2027 |
| Sustainability Ambition 2035 | Four pillars; quantified targets (see Section 20) | Jul 2026 |
| Dividend policy | Payout raised to 25–30% | Sep 2025 |
Guidance FY2026/27
Organic net sales growth of c. 3% (conditional on agricultural markets recovering) and EBITDA margin of 19–20% (KWS PR 23 Sep 2026). Note the margin range is narrower and lower than the 19–21% mid-term band.
Products & Services
Pricing is not publicly disclosed by KWS for any product line (n/d); seed is generally priced per unit/bag with regional price lists through distributors.
Sugarbeet segment
| Product / platform | Description & capabilities | Target customer | Launch / latest | Notes |
|---|---|---|---|---|
| CONVISO SMART system | Sugarbeet varieties tolerant to ALS-inhibitor herbicide (CONVISO ONE, chemistry partner Bayer), allowing simplified weed control with fewer passes | EU/Eastern European sugarbeet growers | Launched c. 2019–2020; expanding | Used on c. 954,000 ha in FY25/26 (874,000 ha prior), c. 27% of global sugarbeet area (AR 25/26) |
| CR+ varieties | High tolerance to Cercospora leaf spot, reducing fungicide needs | Growers in high-disease regions (EU, US) | Ongoing launches | CONVISO SMART + CR+ = c. 63% of segment sales (FY25/26) |
| Combined CONVISO SMART + CR+ varieties | Stacked herbicide tolerance and Cercospora tolerance | EU growers | Launched in several more European countries in FY25/26 | Share rising above-proportionately (AR 25/26) |
| ELSABELLA KWS | First KWS variety officially designated SBR/RTD-tolerant by the German Federal Plant Variety Office; also nematode-resistant and CR+ | German growers in SBR/RTD areas (c. 120,000 ha affected in Germany) | FY25/26 | AR 25/26 |
| LORENZA KWS | Approved variety additionally recognised as SBR/RTD-tolerant | German growers | FY25/26 designation | AR 25/26 |
| BTS SMART 1980 N | New CR+ CONVISO SMART variety with nematode tolerance | Germany | Approved FY25/26 | BTS = Betaseed brand |
| SMART URIELLA KWS | First CONVISO SMART variety with Rhizoctonia resistance | Germany | Approved FY25/26 | AR 25/26 |
| TRUVERA | Broad-spectrum, triple-stacked herbicide tolerance system for North American sugarbeet | US/Canadian growers | US regulatory approval completed; trial varieties registered; launch planned FY2026/27 | AR 25/26 |
| Betaseed brand | US sugarbeet seed brand of KWS | US growers / co-ops | Long-standing | Brand presence confirmed by "BTS" variety naming |
| Beet for feeding (fodder beet) | Fodder beet varieties | Livestock farmers | Ongoing | KWS website |
| Diploid hybrid potato | Development of hybrid true potato seed | Future potato sub-segments | R&D stage | AR 25/26 |
| Sugarbeet powder / food ingredients | Solutions marketed under KWS "Solutions" | Food industry | — | KWS website |
Corn segment
| Product line | Description & capabilities | Target customer | Notes |
|---|---|---|---|
| Silage corn hybrids | High energy/starch yield, digestibility, drought tolerance; dual-purpose types | Dairy/beef and biogas farms in Europe | KWS is European silage corn market leader (AR 25/26) |
| Grain corn hybrids | Early-maturing types with low grain moisture; late-maturing programmes for maritime, continental, Mediterranean zones; drought/heat-tolerant SE Europe lines | European grain growers (France, CEE, SE Europe) | KWS #3 in European grain corn; overall European corn share 13% (11%) (AR 25/26) |
| New 2026 approvals | 10 of 19 newly approved corn varieties in Germany came from KWS (AR 25/26) | German market | FY25/26 |
| Sunflower hybrids | Yield stability, drought tolerance; higher-performing new varieties | France, Spain, Eastern Europe, Ukraine | Sales +35% in FY25/26; target €100m sales by 2035 (AR 25/26) |
| Sorghum, soy, alfalfa | Listed on KWS product pages | Regional | South American sorghum business divested 2024; remaining scale n/d |
Cereals segment
| Product line | Description | Share of segment sales FY25/26 (%) | Notes |
|---|---|---|---|
| Hybrid oilseed rape | Hybrid winter OSR with disease/pest resistance focus (e.g., tolerance to cabbage stem flea beetle under development via genome editing) | 39 (31 prior) | 17% share of European hybrid OSR (Kynetec, Aug 2026); market leader in France and Germany; c. 15% of OSR revenue reinvested in R&D (KWS PR 5 Aug 2026) |
| Hybrid rye | Hybrid rye (KWS Lochow heritage; PollenPlus pollen-shedding technology against ergot — from product literature) | 33 (38 prior) | Rye sales −13% in FY25/26 on low prices in Germany/Poland and Russia decline |
| Wheat | Line varieties; hybrid wheat via blue aleurone (BLA) system in development | 15 (16 prior) | Hybrid wheat launch targeted for first half of 2030s (AR 25/26) |
| Barley (incl. hybrid barley) | Line and hybrid barley; first hybrid barley launched in UK in FY24/25 | 7 (8 prior) | Barley −9%, hybrid barley sales rose sharply from low base |
| Other (peas, catch crops, oats) | Grain peas, mustard and other catch crops, oats | c. 6 (residual) | Low revenues |
Vegetables segment
| Crop | Status | Notes |
|---|---|---|
| Spinach | Core; global market leader | c. two-thirds of segment sales; FY25/26 decline mainly US food-service sub-segment (AR 25/26) |
| Beans | Core (Pop Vriend heritage) | c. one-quarter of segment sales |
| Swiss chard, red beet | Established, small | Positive growth FY25/26 |
| Tomatoes, melons | First new crops commercialised | Sales rising sharply from small base |
| Peppers, cucumbers, watermelons | Pipeline | Commercial entry for all five "fruity" crops planned FY2026/27 |
Segment ambition: c. €100m net sales by 2030 (AR 25/26 Foreword).
Services, digital and licensing
| Offering | Description |
|---|---|
| myKWS | Customer portal / digital farmer services |
| KWS INITIO | Digital/agronomic solution (details n/d) |
| Seed2FEED | Silage/feed value advisory |
| Consulting & crop rotation advisory | Cross-crop agronomic advice ("Your Seed Partner"); Ambition 2035 targets advisory coverage of up to 35m hectares |
| KWS TraitWay | Licensing platform for KWS innovations/traits |
| Organic seed | Organic seed range across crops |
Financial Narrative
All figures continuing operations, EUR M, from AR 25/26 "KWS in Figures" unless marked derived. Note: FY21/22 and FY22/23 figures are as restated in AR 25/26 (continuing operations), which differ materially from originally reported group figures.
Income statement
Pre-tax income FY21/22 and FY22/23 derived (EBIT + net financial result). Diluted EPS equals basic EPS (no dilutive instruments; share count constant at 33.0m). FY25/26 dividend subject to AGM approval on 1 Dec 2026.
Gross profit is only disclosed for the latest two years in the reviewed material:
Source: AR 25/26.
Margins
Net margin derived. Gross margin: 63.1% (FY24/25), 61.2% (FY25/26). Adjusted EBITDA margin (ex special items): 20.4% (FY24/25), 19.3% (FY25/26) (AR 25/26).
Revenue CAGR (FY2021/22–FY2025/26, 4 years): c. 6.3% (derived) — but this is inflated by portfolio and pricing effects in FY22/23–FY23/24; organic growth has been −1.0% (FY25/26) and +1.0% (FY24/25).
Balance sheet
Latest two years in detail (AR 25/26):
Total borrowings and working capital derived.
Cash flow
Dividends paid FY21/22–FY23/24 derived (prior-year DPS × 33.0m shares). KWS does not run buyback programmes; small share purchases are made only for the Employee Stock Purchase Plan (50,164 shares in FY25/26) (AR 25/26). FY25/26 free cash flow benefited from instalments on the North American corn sale price; net cash from investing (continuing) −€50.0m vs −€104.5m. Financing cash flow −€101.8m (repayments €36.8m; dividends €41.3m).
Ratios
ROE, ROA, ROCE from AR 25/26 (ROCE = EBIT / average capital employed; KWS's proxy for ROIC). Net debt/EBITDA and asset turnover derived; earlier years mix group net debt and total assets with continuing-ops EBITDA/sales, overstating leverage slightly.
All derived.
Commentary on trends, inflections and drivers
Growth phase (FY21/22–FY23/24). Continuing-ops sales rose 32% in two years, driven by price increases, strong sugarbeet innovation uptake (CONVISO SMART, CR+), and high crop prices after the Ukraine shock, which encouraged acreage and premium seed purchasing. EBITDA margin peaked at 24.1% in FY23/24, helped by a €28.1m China corn gain.
Plateau and portfolio reset (FY24/25–FY25/26). Sales stalled at c. €1.68bn and then fell 3% to €1.63bn as agricultural commodity prices slumped, EU sugarbeet acreage contracted (c. −10% globally in FY25/26), corn area declined in France and SE Europe, and Russia sales fell on import restrictions/localisation. The underlying (adjusted) EBITDA margin slid from 20.4% to 19.3% — still inside the 19–21% target — with management relying on cost-cutting launched in H1 FY25/26 (selling −3.7%, admin −6.4%, R&D −2.0%).
Balance sheet inflection. The divestment programme collapsed net debt from €565m (FY22/23) to €8.7m (FY25/26) and lifted the equity ratio from 47% to 61%. The financial result swung from −€50.0m to +€1.1m as interest costs fell and AgReliant losses disappeared — the main reason EPS rose 13% despite lower EBIT.
Cash generation. Free cash flow has stabilised at c. €122–123m for two years versus c. €55–57m in FY22/23–FY23/24, reflecting lower capex intensity (6.7% of sales vs 8.3% in FY23/24) and the exit from capital-hungry South American corn. FY25/26 operating cash flow, however, fell 24% due to higher net working capital (inventories +€40.6m; receivables +€47.4m) — a watch-point.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Overview
| Segment | Contents | Seasonality |
|---|---|---|
Sugarbeet | Sugarbeet seed breeding, production and sales; development of diploid hybrid potatoes | Spring sowing; sales mostly Jan–Jun (H2) |
Corn | Corn (silage, grain) and sunflower seed — now Europe-focused after North American and South American exits | Spring sowing; sales mostly H2 |
Cereals | Rye, wheat, barley, oilseed rape seed; also peas, catch crops (e.g., mustard), oats | Autumn sowing; sales mostly Jul–Dec (H1) |
Vegetables | Spinach, beans, Swiss chard, red beet, tomatoes; pipeline in peppers, cucumbers, melons, watermelons | North America is largest market |
Corporate | Own farms (Germany, France, Poland); central functions; basic research costs not allocated to segments | Structurally negative EBITDA |
Sugarbeet | Europe 61% (62%), North America 23% (27%) of segment sales; strong growth in Middle East (Türkiye, Egypt) and Asia; declines in Western/Northern EU and North America | AR 25/26 |
Corn | Europe-focused; Russia declined; Europe ex-Russia up despite lower acreage | AR 25/26 |
Cereals | Core markets Germany, Poland, UK, France, Scandinavia; OSR growth in Germany, France, Romania; rye down in Germany/Poland/Russia | AR 25/26 |
Vegetables | North America largest market; US spinach (food service) weak; Europe up; China high comparison base | AR 25/26 |
Revenue by Segment
| Segment | FY2023/24 | FY2024/25 | FY2025/26 |
|---|---|---|---|
Sugarbeet net sales (EUR Mn) | 864.9 | 871.8 | 854.2 |
Corn net sales (EUR Mn) | 465.0 | 458.1 | 433.6 |
Cereals net sales (EUR Mn) | 275.9 | 263.3 | 263.9 |
Vegetables net sales (EUR Mn) | 62.1 | 72.1 | 67.5 |
Corporate net sales (EUR Mn) | 9.2 | 11.3 | 7.5 |
Group net sales (EUR Mn) | 1,678.1 | 1,676.6 | 1,626.8 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansResults by Segment
| Segment | FY2023/24 | FY2024/25 | FY2025/26 |
|---|---|---|---|
Sugarbeet EBITDA (EUR Mn) | 378.1 | 397.0 | 358.1 |
Corn EBITDA (EUR Mn) | 82.2 | 52.7 | 92.2 |
Cereals EBITDA (EUR Mn) | 59.8 | 42.9 | 34.6 |
Vegetables EBITDA (EUR Mn) | -11.2 | -22.0 | -25.8 |
Corporate EBITDA (EUR Mn) | -103.9 | -120.1 | -116.0 |
Group EBITDA (EUR Mn) | 404.9 | 350.5 | 343.1 |
Segment Margins & Growth (%)
| Segment | FY2023/24 | FY2024/25 | FY2025/26 |
|---|---|---|---|
Sugarbeet EBITDA margin (%) | 43.7 | 45.5 | 41.9 |
Corn EBITDA margin (%) | 17.7 | 11.5 | 21.3 |
Cereals EBITDA margin (%) | 21.7 | 16.3 | 13.1 |
Vegetables EBITDA margin (%) | -18.0 | -30.4 | -38.2 |
Segment Revenue
| Segment | EBIT FY25/26 | EBIT FY24/25 | D&A FY25/26 | Capex FY25/26 | Capex FY24/25 | Avg. capital employed FY25/26 | ROCE FY25/26 (%) | ROCE FY24/25 (%) |
|---|---|---|---|---|---|---|---|---|
Sugarbeet | 326.6 | 367.2 | 31.5 | 24.7 | 41.2 | 564.8 | 57.8 | 70.3 |
Corn | 68.5 | 29.6 | 23.7 | 4.2 | 11.8 | 398.6 | 17.2 | 7.4 |
Cereals | 22.1 | 32.1 | 12.6 | 3.3 | 10.7 | 173.8 | 12.7 | 19.9 |
Vegetables | -41.6 | -45.8 | 15.8 | 16.7 | 18.6 | 448.1 | -9.3 | -10.6 |
Corporate | -136.6 | -135.4 | 20.6 | 59.6 | 37.4 | — | — | — |
Segment Revenue (Share FY24/25 (%)–Share of group sales FY25/26 (%))
| Segment | Reported growth FY25/26 (%) | Organic growth FY25/26 (%) | Share of group sales FY25/26 (%) | Share FY24/25 (%) |
|---|---|---|---|---|
Sugarbeet | -2.0 | -0.6 | 52.5 | 52.0 |
Corn | -5.3 | -1.6 | 26.7 | 27.3 |
Cereals | 0.2 | 0.6 | 16.2 | 15.7 |
Vegetables | -6.4 | -6.8 | 4.2 | 4.3 |
Corporate | -33.7 | — | 0.4 | 0.7 |
Group | -3.0 | -1.0 | 100 | 100 |
Income Statement and Per-Share Data
| Metric | FY2021/22 | FY2022/23 | FY2023/24 | FY2024/25 | FY2025/26 |
|---|---|---|---|---|---|
Net sales (EUR Mn) | 1,275.8 | 1,500.3 | 1,678.1 | 1,676.6 | 1,626.8 |
EBITDA (EUR Mn) | 230.0 | 278.8 | 404.9 | 350.5 | 343.1 |
EBIT (EUR Mn) | 141.5 | 195.1 | 302.0 | 247.6 | 239.0 |
Net financial result (EUR Mn) | -7.2 | -23.8 | -50.0 | -35.4 | 1.1 |
Pre-tax income (EUR Mn) | 134.3 | 171.3 | 252.0 | 212.2 | 240.1 |
Net income continuing ops (EUR Mn) | 106.4 | 126.1 | 184.1 | 140.0 | 158.4 |
Net income discontinued ops (EUR Mn) | 1.3 | 0.9 | -53.2 | 96.4 | 2.5 |
Net income group (EUR Mn) | 107.8 | 127.0 | 130.8 | 236.3 | 160.8 |
EPS continuing basic (EUR) | 3.23 | 3.82 | 5.58 | 4.24 | 4.80 |
EPS group basic (EUR) | 3.27 | 3.85 | 3.96 | 7.16 | 4.87 |
Dividend per share (EUR) | 0.80 | 0.90 | 1.00 | 1.25 | 1.30 |
D&A (EUR Mn) | 88.5 | 83.7 | 102.9 | 102.9 | 104.1 |
Key Financials
| Metric | FY2024/25 | FY2025/26 |
|---|---|---|
Gross profit (EUR Mn) | 1,057.4 | 995.8 |
Cost of sales (EUR Mn) | 619.2 | 631.0 |
Selling expenses (EUR Mn) | 296.6 | 285.8 |
R&D expenses (EUR Mn) | 349.0 | 342.1 |
Administrative expenses (EUR Mn) | 165.3 | 154.7 |
Other operating income net (EUR Mn) | 1.2 | 25.7 |
Income taxes (EUR Mn) | 72.2 | 81.7 |
Margin Analysis (%)
| Metric | FY2021/22 | FY2022/23 | FY2023/24 | FY2024/25 | FY2025/26 |
|---|---|---|---|---|---|
EBITDA margin (%) | 18.0 | 18.6 | 24.1 | 20.9 | 21.1 |
EBIT margin (%) | 11.1 | 13.0 | 18.0 | 14.8 | 14.7 |
Net margin continuing (%) | 8.3 | 8.4 | 11.0 | 8.4 | 9.7 |
R&D intensity (%) | 20.5 | 20.0 | 19.4 | 20.8 | 21.0 |
Financial Analysis
| Item | Fiscal year | Amount (EUR Mn) | Line |
|---|---|---|---|
Gain on divestment of Chinese corn business | FY23/24 | +28.1 | EBITDA (Corn) |
Reversal of VAT risk provision | FY24/25 | +7.7 | EBITDA (Sugarbeet) |
AgReliant operating loss and impairment | FY24/25 | -20.7 | Result from equity investments |
Gain on sale of South American corn/sorghum | FY24/25 | +96.4 (after tax) | Discontinued ops |
Sale of licence rights (North American corn) | FY25/26 | +29.0 | EBITDA (Corn) |
Gain on disposal of AgReliant shares | FY25/26 | +7.7 | Result from equity investments (9M PR) |
Antitrust provision (Cereals) | FY25/26 | -5.0 | EBITDA (Cereals) |
Negative FX impact on EBITDA | FY25/26 | c. -14 to -16 | EBITDA (PR says c. €14m; AR says c. €16m — discrepancy noted) |
Balance Sheet and Margin Analysis (%)
| Metric | FY2021/22 | FY2022/23 | FY2023/24 | FY2024/25 | FY2025/26 |
|---|---|---|---|---|---|
Total assets (EUR Mn) | 2,651.8 | 2,749.6 | 2,956.1 | 2,676.2 | 2,824.2 |
Equity (EUR Mn) | 1,245.9 | 1,291.1 | 1,399.9 | 1,601.5 | 1,728.2 |
Equity ratio (%) | 47.0 | 47.0 | 47.4 | 59.8 | 61.2 |
Net debt (EUR Mn) | 521.9 | 565.2 | 385.1 | 61.6 | 8.7 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansBalance Sheet
| Metric | FY2024/25 | FY2025/26 |
|---|---|---|
Cash and cash equivalents (EUR Mn) | 374.0 | 394.4 |
Short-term borrowings (EUR Mn) | 42.1 | 153.7 |
Long-term borrowings (EUR Mn) | 393.4 | 249.3 |
Total borrowings (EUR Mn) | 435.5 | 403.0 |
Noncurrent assets (EUR Mn) | 1,126.2 | 1,223.4 |
Current assets (EUR Mn) | 1,471.0 | 1,600.8 |
Assets held for sale (EUR Mn) | 79.0 | 0.0 |
Inventories (EUR Mn) | 420.3 | 460.9 |
Trade receivables (EUR Mn) | 489.3 | 536.7 |
Property, plant and equipment (EUR Mn) | 661.0 | 695.6 |
Noncurrent liabilities (EUR Mn) | 553.3 | 411.4 |
Current liabilities (EUR Mn) | 521.4 | 684.6 |
Working capital (EUR Mn) | 949.6 | 916.2 |
Undrawn committed facilities (EUR Mn) | 432.1 | 430.7 |
Contingent liabilities & other obligations (EUR Mn) | 172.5 | 36.8 |
Cash Flow
| Metric | FY2021/22 | FY2022/23 | FY2023/24 | FY2024/25 | FY2025/26 |
|---|---|---|---|---|---|
Operating cash flow continuing (EUR Mn) | 200.6 | 158.5 | 157.9 | 227.7 | 172.6 |
Capital expenditure (EUR Mn) | 83.4 | 100.8 | 139.9 | 119.6 | 108.6 |
Free cash flow continuing (EUR Mn) | 113.6 | 55.4 | 56.8 | 123.2 | 122.5 |
Dividends paid (EUR Mn) | 26.4 | 26.4 | 29.7 | 33.0 | 41.3 |
Share buybacks (EUR Mn) | 0 | 0 | 0 | 0 | 0 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2021/22 | FY2022/23 | FY2023/24 | FY2024/25 | FY2025/26 |
|---|---|---|---|---|---|
ROE (%) | 10.4 | 10.3 | 14.6 | 10.2 | 10.1 |
ROA (%) | 4.7 | 5.1 | 7.3 | 5.0 | 6.3 |
ROCE avg (%) | 8.5 | 10.7 | 16.6 | 13.9 | 12.6 |
Net debt to EBITDA (x) | 2.27 | 2.03 | 0.95 | 0.18 | 0.03 |
Asset turnover (x) | 0.48 | 0.55 | 0.57 | 0.63 | 0.58 |
Financial Ratios (x) and Working Capital (Days)
| Ratio (latest two years) | FY2024/25 | FY2025/26 |
|---|---|---|
Current ratio (x) | 2.82 | 2.34 |
Debt to equity (x) | 0.27 | 0.23 |
Interest coverage EBIT / net interest (x) | 39.3 | 39.8 |
Days inventory (on cost of sales) | 248 | 267 |
Days sales outstanding | 107 | 120 |
Revenue by Region (%)
| Region | FY2024/25 | FY2025/26 |
|---|---|---|
Germany share of sales (%) | 17.6 | 17.8 |
Europe excl Germany share of sales (%) | 55.9 | 55.8 |
North and South America share of sales (%) | 18.5 | 15.6 |
Rest of world share of sales (%) | 8.0 | 10.8 |
Revenue by Region
| Region | FY2024/25 | FY2025/26 | Growth (%) |
|---|---|---|---|
Germany sales (EUR Mn) | 295.1 | 289.6 | -1.9 |
Europe excl Germany sales (EUR Mn) | 937.2 | 907.8 | -3.1 |
Americas sales (EUR Mn) | 310.2 | 253.8 | -18.2 |
Rest of world sales (EUR Mn) | 134.1 | 175.7 | 31.0 |
Valuation Snapshot
| Metric | Value | Source |
|---|---|---|
Close 30 Jun 2025 | €61.70 | AR 25/26 |
Close 30 Jun 2026 | €67.40 (+9.2% over FY; outperformed DAX +4.5% and SDAX +2.7%) | AR 25/26 |
FY25/26 high / low | €79.60 (5 May 2026) / €61.40 (1 Jul 2025) | AR 25/26 |
52-week high (to Sep 2026) | €79.50 (9 Sep 2026, Lang & Schwarz) — conflicts slightly with €79.60 XETRA intra-FY high | boerse-express |
Price 11 Sep 2026 | €76.70 | boerse-express |
Post-results 23 Sep 2026 | €69.60 intraday low (−11.5%); c. €71–72 later in day | Börsen-Zeitung; goldesel |
Avg daily XETRA volume | 15,186 shares (FY25/26) vs 12,364 | AR 25/26 |
Metric | FY2021/22 | FY2022/23 |
Dividend per share (EUR) | 0.80 | 0.90 |
EPS continuing (EUR) | 3.23 | 3.82 |
Valuation Snapshot by Multiple
| Multiple | Value | Basis |
|---|---|---|
Market cap | c. €2.31bn | 33.0m × €70 |
Enterprise value | c. €2.32bn |
|
P/E (FY25/26 continuing EPS €4.80) | c. 14.6x | — |
P/E (FY26/27 implied EPS c. €4.74, finanzen.net) | c. 14.8x | — |
EV/EBITDA (reported €343.1m) | c. 6.8x | — |
EV/EBITDA (adjusted €314.1m) | c. 7.4x | — |
EV/Sales | c. 1.4x | — |
P/B (equity €1,728.2m) | c. 1.3x | — |
Dividend yield (€1.30) | c. 1.9% | — |
Analyst Ratings & Targets
| Broker | Rating | Target | Date |
|---|---|---|---|
Baader Bank | Add | €85 | Raised Jul 2026; confirmed after FY results Sep 2026 |
Kepler Cheuvreux | Hold (downgraded from Buy) | — | 2025/26, date n/d |
Consensus FY25/26 EPS (pre-results) | €5.57 vs actual €4.80 | — | goldesel, Sep 2026 |
Coverage breadth | c. 3–4 analysts with EPS estimates | — | theScreener, Jul–Aug 2026 |
Capital Markets
| Item | Detail |
|---|---|
Buyback authorisations | None active for capital return; treasury purchases only for Employee Stock Purchase Plan (§71(1) No. 2 AktG) |
Credit ratings (Moody's/S&P/Fitch) | No public credit rating identified (n/d) |
Financing instruments | Syndicated credit line; EIB loan (R&D); Schuldschein (borrower's notes); commercial paper |
Debt maturity profile | €153.7m short-term (within 12 months, incl. reclassified tranches); €249.3m long-term; detailed ladder n/d |
Undrawn committed lines | €430.7m (30 Jun 2026) |
Analyst Conclusions
Management guidance (FY2026/27)
| Item | Guidance | Mid-term target (2025–28) |
|---|---|---|
| Organic net sales growth | c. +3% (if agricultural markets recover) | 3–5% p.a. average |
| EBITDA margin | 19–20% | 19–21% |
| Dividend payout | 25–30% of adjusted net income | Same |
| Implied EBITDA | c. €335m (finanzen.net estimate) | — |
| Implied EPS | c. €4.74 (finanzen.net estimate) | — |
Bull case
-
Sugarbeet cycle turns while share gains persist. KWS held organic sugarbeet sales nearly flat (−0.6%) through a 10% acreage collapse; sugar prices began recovering by late FY25/26, so any acreage rebound flows through at c. 42–45% margins with TRUVERA adding a US catalyst in FY26/27.
-
Balance sheet as a weapon. With net debt of €8.7m and €430.7m undrawn lines, KWS can fund vegetables, hybrid wheat and genome editing without dilution, while lifting dividends (DPS doubled in eight years) — and could pursue bolt-on acquisitions.
-
Innovation optionality is under-priced. EU NGT approval (June 2026), hybrid wheat (2030s), OSR momentum (+21% H1, 17% European hybrid share) and sunflower (+35%) give multiple growth vectors; at c. 7x EV/EBITDA these options are attained cheaply.
Bear case
-
Structural growth gap. Organic growth was −1% in FY25/26 and FY26/27 guidance sits at the bottom of the 3–5% range — and is conditional on market recovery. The guided 19–20% margin is below the old 19–21% range, implying no operating leverage.
-
Earnings quality and concentration. Headline FY25/26 EBITDA leaned on a €29.0m one-off; sugarbeet alone earns more than the group, so any erosion of its pricing (competitors, sugar policy) has outsized impact. Cereals and vegetables are deteriorating (antitrust provision; vegetable losses widening).
-
Rising legal and geopolitical noise. Antitrust probes in France and Türkiye, Russia localisation pressures, Iran-related risk and FX (USD, TRY) could compress margins further; the consensus EPS miss (€4.80 vs €5.57) suggests the market overestimated resilience.
Catalysts and monitorables (next 12 months)
| Date (expected) | Catalyst / monitorable |
|---|---|
| Nov 2026 | Q1 FY26/27 statement — cereals/OSR autumn sales, Russia trend |
| 1 Dec 2026 | AGM — €1.30 dividend; PwC auditor appointment |
| Q4 2026 | Corteva seed spin-off (Vylor) — new pure-play comparables and competitive behaviour |
| Feb 2027 | H1 FY26/27 — guidance confirmation/revision; vegetables commercial launches |
| Spring 2027 | Sugarbeet and corn sowing season — EU beet acreage response to sugar prices; TRUVERA US launch uptake |
| May 2027 | 9M FY26/27 — full-year visibility |
| Ongoing | French and Turkish antitrust outcomes; EU NGT implementation timeline; working-capital normalisation; North American sale-price instalments |
Analyst verdict
KWS enters FY2026/27 as a fundamentally sound but temporarily growth-starved franchise. The portfolio surgery of 2023–2025 — exiting China, South America and North American corn — achieved its objectives: net debt fell from €565m to under €9m, the equity ratio climbed above 61%, free cash flow doubled to a stable c. €122m, and the financial result swung positive. What the market punished on 23 September 2026 was not the balance sheet but the operating trajectory: organic sales fell 1% against a 3–5% ambition, adjusted EBITDA margin slipped to 19.3%, EPS missed consensus by roughly 14%, and new guidance (c. 3% organic growth, 19–20% margin) was conditional and below expectations.
The core investment debate therefore centres on sugarbeet. KWS's innovation lead there is real and measurable — CONVISO SMART covers over a quarter of world beet area and innovations represent 63% of segment sales — and the company gained share in a year when acreage fell by a tenth. That is the signature of pricing power. If sugar prices sustain their late-FY25/26 recovery, acreage should normalise and the segment's 40%-plus margins will restore group growth with little incremental cost.
Against that, investors must accept a multi-year drag from vegetables (c. €26m EBITDA losses, €448m capital employed) whose payoff — around €100m sales by 2030 — remains modest, plus a cereals business absorbing legal costs. Genome editing and hybrid wheat are genuine long-dated options but will not move earnings before the late 2020s and 2030s respectively.
At roughly 15x earnings, c. 7x EV/EBITDA and 1.3x book, with a c. 2% yield and essentially no leverage, the valuation already discounts much of the near-term disappointment. Our synthesis is a constructive-hold stance: the downside appears cushioned by balance sheet and franchise quality, while a re-rating likely requires evidence — most plausibly in the spring 2027 sowing season — that organic growth is back inside the 3–5% corridor.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title / responsibilities | Joined Board | Prior roles | Age (if disclosed) |
|---|---|---|---|---|
Dr. Felix Büchting | Spokesperson (CEO-equivalent); Research & Breeding, HR, Farming, Corporate Office & Services, Group Strategy | n/d (Spokesperson since c. 2023) | Member of founding-related Büchting family | — |
Dr. Jörn Andreas | CFO; Finance & Controlling, Global Business Operations, Legal Services & IP, IT, Governance/Risk/Audit, Investor Relations | 1 Jan 2025 | Symrise AG Executive Board, responsible for Scent & Care segment (until Sep 2024) | 43 at appointment (Nov 2024) |
Nicolás Wielandt | Sugarbeet, Vegetables (previously Corn) | — | Led corn divestments; long KWS career | — |
Sebastian Talg | Corn, Cereals, Oilseed Rape & Special Crops (incl. Organic), Marketing & Communications | 1 Sep 2025 (AR 25/26) | — | 46 at appointment (Nov 2024) |
Board of Directors
| Name | Role | Notes |
|---|---|---|
Dr. Hagen Duenbostel | Chairman | Former Spokesperson of the KWS Executive Board (led 2018 Nunhems bid as CEO) |
Dr. Marie Theres Schnell | Deputy Chairwoman | Previously Chairwoman (2024) |
Christine Coenen | Employee representative (until 31 Aug 2026) | Joined KWS 1988; Chair of European Employees' Committee; retired |
Antoine Rombouts | Employee representative (from 1 Sep 2026); Audit Committee member | 26 years in KWS Purchasing & Logistics |
Other members | n/d in reviewed excerpt | — |
Board & Management Changes
| Date | Change | Context |
|---|---|---|
Sep 2024 | CFO Eva Kienle announces departure | Described as surprising by Börsen-Zeitung |
5 Nov 2024 | Andreas and Talg appointed | Board "rejuvenation" |
1 Jan 2025 | Andreas becomes CFO | Handover with Kienle (left end Jan 2025) |
| 2025 | Wielandt moves from Corn to Sugarbeet & Vegetables | Following Hofmann exit |
1 Sep 2025 | Talg joins Executive Board | Takes Corn, Cereals, OSR |
30 Sep 2025 | Dr. Peter Hofmann leaves | Contract end as agreed |
1 Sep 2026 | Rombouts succeeds Coenen on Supervisory Board | Employee representative |
Major Shareholders
| Holder | Stake (%) |
|---|---|
Families Büchting, Arend Oetker and Tessner (pooled) | 69.3 |
of which Tessner Beteiligungs GmbH | 15.4 |
Free float | 30.7 |
Competitive Landscape
Competitors by Segment
| Segment | Competitor | Ownership / type | KWS relative positioning |
|---|---|---|---|
Sugarbeet | SESVanderHave | Florimond Desprez group (private, Belgium/France) | KWS #1 globally, gaining share |
Sugarbeet | Hilleshög | DLF (private, Denmark) | KWS leads |
Sugarbeet | Strube | Private (Germany) | KWS leads |
Sugarbeet | Florimond Desprez / Betaseed-type US rivals (e.g., ACH Seeds, Crystal Beet Seed) | Private/co-op | KWS strong in US via Betaseed |
Corn (Europe) | Corteva (Pioneer); Vylor (planned Corteva seed spin-off) | Listed (US) | KWS #1 silage, #3 grain; 13% overall |
Corn (Europe) | Bayer (DEKALB) | Listed (Germany) | Large-scale biotech competitor |
Corn (Europe) | Limagrain Field Seeds (LG) | Co-op owned (France) | Close European peer |
Corn / sunflower | Syngenta (NK) | ChemChina/Sinochem | Strong in sunflower and grain corn |
Corn / sunflower | Lidea, RAGT, MAS Seeds (Euralis) | European co-ops/family | Mid-sized rivals |
Cereals / OSR | Limagrain (LG), RAGT, DSV, NPZ, Saaten-Union partners, Elsoms | European private/co-op | KWS leader in hybrid rye, #2/leading OSR in Europe |
Vegetables | Bayer (Seminis/De Ruiter), BASF (Nunhems), Rijk Zwaan, Enza Zaden, Syngenta, Sakata, Vilmorin (HM.Clause, Hazera) | Mixed | KWS #1 spinach; sub-scale overall |
Peer Comparison FY2025
| Company | Latest revenue (indicative) | Seed-only? | EBITDA margin (indicative) | R&D intensity (indicative) |
|---|---|---|---|---|
KWS (FY25/26) | €1.63bn | Yes | 19.3% adj. (21.1% reported) | 21.0% |
Corteva Seed (CY2025) | c. US$9–10bn seed sales (n/v) | Seed segment of agri-input group | c. 25–30% segment margin (n/v) | c. 8–9% group (n/v) |
Vilmorin & Cie (FY24/25) | c. €1.9–2.0bn (n/v) | Yes (field + vegetable seeds) | c. 15–18% (n/v) | c. 16–17% (n/v) |
Bayer Crop Science (CY2025) | c. €21–22bn incl. crop protection (n/v) | No | c. 20–23% (n/v) | c. 10–11% (n/v) |
Recent Developments
--



